Explore our comprehensive coverage of biopharma, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's approval of the first in vivo CRISPR base-editing therapy permanently silences the PCSK9 gene, shifting pharmaceutical economics from chroni...
Read Full Story →
HealthcareThe FDA’s approval of an oral MASH triple-agonist, combined with CMS physician fee schedule restru...
Medical ResearchThe FDA's August 2026 approvals of oncolytic viruses and CELMoD therapies fundamentally reset the bi...
InfluencersThe U.S. healthcare policy apparatus executed a synchronized structural deleveraging in 2026, define...
